¿Patología dual?revisando la conceptualización de la comorbilidad en adicciones

Referencias bibliográficas

• Albert, P.R., Benkelfat, C. y Descarries, L. (2012). The neurobiology of depression—revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philoshopical Transactions of the Royal Society B, 367, 2378–81.
• Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., . . . Murray, R. (2018). Analysis of shared heritability in common disorders of the brain. Science, 360(6395). doi:10.1126/science.aap8757
• Arango, C., Dragioti, E., Solmi, M., Cortese, S., Domschke, K., Murray, R. M., . . . Fusar-Poli, P. (2021). Risk and protective factors for mental disorders beyond genetics: An evidence-based atlas. World Psychiatry, 20(3), 417-436. doi:10.1002/wps.20894
• Arranz, B., Garriga, M., Bernardo, M., González-Pinto, A., Arrojo, M., Torrens, M., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use. Adicciones, 34(2), 110-127. doi:10.20882/adicciones.1504
• Ashford, R. D., Brown, A., Brown, T., Callis, J., Cleveland, H. H., Eisenhart, E., Groover, H., Hayes, N., Johnston, T., Kimball, T., Manteuffel, B., McDaniel, J., Montgomery, L., Phillips, S., Polacek, M., Statman, M. y Whitney, J. (2019). Defining and operationalizing the phenomena of recovery: A working definition from the recovery science research collaborative. Addiction Research y Theory, 27(3), 179-188. https://doi.org/10.1080/16066359.2018.1515352
• Becoña, E. (2018). Brain disease or biopsychosocial model in addiction? Remembering the Vietnam Veteran Study. Psicothema, 30(3).
• Carballo, J.L. (2023). Editorial: Sobre la recuperación en adicciones. Health and addictions, 23(1), 1-5.
• Caspi, A., Houts, R. M., Ambler, A., Danese, A., Elliott, M. L., Hariri, A., . . . Moffitt, T. E. (2020). Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study. JAMA Netw Open, 3(4), e203221. doi:10.1001/jamanetworkopen.2020.3221
• Caspi, A. y Moffitt, T. E. (2018). All for one and one for all: Mental disorders in one dimension. American Journal of Psychiatry, 175(9), 831-844. doi:10.1176/appi.ajp.2018.17121383
• Compton, W. M., Thomas, Y. F., Stinson, F. S. y Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576. doi:10.1001/archpsyc.64.5.566
• Cowlishaw, S. y Hakes, J. K. (2015). Pathological and problem gambling in substance use treatment: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Americal Journal of Addiction, 24(5), 467-474. doi:10.1111/ajad.12242
• Cunill, R., Castells, X., González-Pinto, A., Arrojo, M., Bernardo, M., Sáiz, P. A., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use. Adicciones, 34(2), 168-178. doi:10.20882/adicciones.1569
• Cuthbert, B.N. (2014). The RDoC framework: Facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry, 13(1).
• Engels, G.L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129-36. doi: 10.1126/science.847460.
• Fan, A. Z., Chou, S. P., Zhang, H., Jung, J. y Grant, B. F. (2019). Prevalence and correlates of past-year recovery from DSM-5 alcohol use disorder: Results from National Epidemiologic Survey on Alcohol and Related Conditions-III. Alcoholism: Clinical and Experimental Research, 43(11), 2406-2420. https://doi.org/10.1111/acer.14192
• Forbes, M.K., Tackett, J.L., Markon, K.E. y Krueger, R.F. (2016). Beyond comorbidity: Toward a dimensional and hierarchal approach to understanding psychopathology across the lifespan. Development and Psychopathology, 28(4 Pt 1), 971-86. 10.1017/S0954579416000651
• González-Pinto, A., Goikolea, J. M., Zorrilla, I., Bernardo, M., Arrojo, M., Cunill, R., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with bipolar disorder and comorbid substance use. Adicciones, 34(2), 142-156. doi:10.20882/adicciones.1528
• Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., . . . Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72(8), 757-766. doi:10.1001/jamapsychiatry.2015.0584
• Haslam, N., Holland, E. y Kuppens, P. (2021). Categories versus dimensions in personality and psychopathology: A quantitative review of taxometric research. Psychological Medicine, 42(5),903–920.
• Heilig, M., McKillop, J., Rehm, J., Leggio, L. y Vanderschuren, L.J.M.J. (2021). Addiction as a brain disease revised: Why it still matters, and the need for consilience. Neuropsychopharmacology, 46, 1715-1723. https://doi.org/10.1038/s41386-020-00950-y.
• Kelly, J. F., Bergman, B. G., Hoeppner, B. B., Vilsaint, C. y White, W. L. (2017). Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug and Alcohol Dependence, 181, 162-169. https://doi.org/10.1016/j.drugalcdep.2017.09.028
• Kotov, R., Krueger, R.F., Watson, D., Achenbach, T.M., Althoff, R., Bagby, R.M… Brown, T.A. (2017). The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. Journal of Abnormal Psychology, 126(4), 457-477. doi: 10.1037/abn0000258.
• Krueger, R. F. y Markon, K. E. (2006). Reinterpreting comorbidity: A model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology, 2, 111-133. doi:10.1146/annurev.clinpsy.2.022305.095213
• Krueger, R.F. y Markon, K.E. (2011). A dimensional-spectrum model of psychopathology progress and opportunities. Archives of General Psychiatry, 68(1), 10-1. doi: 10.1001/archgenpsychiatry.2010.188.
• Lahey, B. B., Applegate, B., Hakes, J. K., Zald, D. H., Hariri, A. R. y Rathouz, P. J. (2012). Is there a general factor of prevalent psychopathology during adulthood? Journal of Abnormal Psychology, 121(4), 971-977. doi:10.1037/a0028355
• Lev-Ran, S., Imtiaz, S., Rehm, J. y Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). American Journal of Addictions, 22(2), 93-98. doi:10.1111/j.1521-0391.2013.00304.x
• Lehman, A.F., Myers, C.P. y Corty, E. (1989). Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital Community Psychiatry, 40, 1019-1025.
• Lüscher, C., Robins, T. W. y Everitt, B. J. (2020). The transition to compulsion in addiction. Nature Reviews Neuroscience, 21(5). 247–263. doi:10.1038/s41583-020-0289-z.
• McGrath, J. J., Lim, C. C. W., Plana-Ripoll, O., Holtz, Y., Agerbo, E., Momen, N. C., . . . de Jonge, P. (2020). Comorbidity within mental disorders: A comprehensive analysis based on 145 990 survey respondents from 27 countries. Epidemiology and Psychiatric Sciences, 29, e153. doi:10.1017/s2045796020000633
• Merikangas, K. R., He, J. P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., . . . Swendsen, J. (2010). Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 49(10), 980-989. doi:10.1016/j.jaac.2010.05.017
• Moncrieff, J., Cooper, R.E., Stockmann, T., Amendola, S., Hengartner, M.P. y Horowitz, M.A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28, 3243-3256.
• National Institue on Drug Abuse (2020). Common Comorbidities with Substance Use Disorders Research Report. National Institutes on Drug Abuse.
• Pereiro, C., Pino, C., Flórez, G., Arrojo, M. y Becoña, E. (2013). Psychiatric comorbidity in patients from the addictive disorders assistance units of Galicia: The COPSIAD study. PLoS One, 8(6), e66451. doi:10.1371/journal.pone.0066451
• Plana-Ripoll, O., Pedersen, C. B., Holtz, Y., Benros, M. E., Dalsgaard, S., de Jonge, P., . . . McGrath, J. J. (2019). Exploring comorbidity within mental disorders among a Danish national population. JAMA Psychiatry, 76(3), 259-270. doi:10.1001/jamapsychiatry.2018.3658
• Real Academia Nacional de Medicina de España (n.d.). Patología no es sinónimo de enfermedad. https://www.ranm.es/terminolog%C3%ADa-m%C3%A9dica/recomendaciones-de-la-ranm/3610-patologia-no-es-sinonimo-de-enfermedad.html
• Room, R. (2021). No level has primacy in what is called addiction: “Addiction is a social disease” would be just as tenable. Neuropsychopharmacology, 46(1712).
• Sáiz, P. A., Flórez, G., Arrojo, M., Bernardo, M., González-Pinto, A., Goikolea, J. M., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with an anxiety disorder and comorbid substance use. Adicciones, 34(2), 157-167. doi:10.20882/adicciones.1548
• Sáiz Martínez, P.A., Jimenez Treviño, L., Díaz Mesa, E.M., García-Portilla González M.P., Marina González, P., Al-Halabí, S.,… Ruiz, P. (2014). Patología dual en trastornos de ansiedad: Recomendaciones en el tratamiento farmacológico. Adicciones, 26, 254-274.
• Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, S. J. y Kendler, K. S. (2019). Psychiatric genetics and the structure of psychopathology. Mol Psychiatry, 24(3), 409-420. doi:10.1038/s41380-017-0010-4
• Strain, E.C. (2022). Editorial: The defining characteristic of substance use disorders. Drug and Alcohol Dependence, 230. https://doi.org/10.1016/j.drugalcdep.2021.109207
• Szerman, N., Torrens, M., Maldonado, R., Balhara, Y. P. S., Salom, C., Maremmani, I., . . . Baler, R. (2022). Addictive and other mental disorders: A call for a standardized definition of dual disorders. Translational Psychiatry, 12(1), 446. doi:10.1038/s41398-022-02212-5
• Thompson, P., Jahanshad, N., Ching, C.R.K., Salminen, L.E., Thomopoulos, S.I., Bright, J… for the ENIGMA Consortium (2020). ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Translational Psychiatry, 10(100). https://doi.org/10.1038/s41398-020-0705-1
• Torrens, M., Tirado-Muñoz, J., Fonseca, F., Farré, M., González-Pinto, A., Arrojo, M., . . . San, L. (2022). Clinical practice guideline on pharmacological and psychological management of adult patients with depression and a comorbid substance use disorder. Adicciones, 34(2), 128-141. doi:10.20882/adicciones.1559
• Trujols, J. y Allende, S. (2018). La adicción como enfermedad: ¿Mitigando o alimentando el estigma?. Adicciones, 30(3).
• Volkow, N. D., Michaelides, M. y Baler, R. (2019). The Neuroscience of Drug Reward and Addiction. Physiological Reviews, 99(4). doi: 10.1152/physrev.00014.2018.
• West, R. y Brown, J. (2013). Theories of addiction. John Wiley y Sons.
• World Psychiatric Association (n.d.). 10 basic points on dual Pathology: Addiction and other mental illnesses. https://www.patologiadual.es/docs/wpa-10basic-points-dual-pathology.pdf